Investor's Business Daily on MSN28m
Novocure Launches 40% After Pancreatic Cancer Treatment SucceedsNovocure stock catapulted early Monday after the company's cancer-treating device succeeded in a study of patients with pancreatic cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback